Haoxi Health shares surge 15.77% after-hours after announcing strategic AI health partnership with Eaglepoint AI.

Haoxi Health Technology surged 15.77% in after-hours trading following the announcement of a three-year strategic partnership with Eaglepoint AI to develop an AI-powered health management platform in China. The collaboration combines Haoxi’s marketing networks with Eaglepoint’s Aquila data engine and multimodal model evaluation system to launch the "AI Digital Health Manager" SaaS platform, targeting sub-healthy and chronic disease populations. The partnership emphasizes preventive healthcare applications, including intelligent nutrition and digital therapeutics, and aims to enhance digital marketing ROI for healthcare clients while improving model iteration efficiency by 3.5 times. The CEO highlighted the strategic alignment of Haoxi’s traffic advantages with Eaglepoint’s algorithmic capabilities, positioning the initiative as a key entry into the AI-enabled healthcare sector. The news aligns with investor optimism about expanding AI-driven health solutions and data-driven marketing opportunities.